Product Images Buprenorphine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Buprenorphine NDC 0228-3153 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The following chemical structure for Buprenorphine HCl, USP has the molecular formula C29 H41 NO4 • HCl and the molecular weight is 504.10. It is a white or off-white crystalline powder, sparingly soluble in water, freely soluble in methanol, soluble in alcohol and practically insoluble in cyclohexane. - image 1

The following chemical structure for Buprenorphine HCl, USP has the molecular formula C29 H41 NO4 • HCl and the molecular weight is 504.10. It is a white or off-white crystalline powder, sparingly soluble in water, freely soluble in methanol, soluble in alcohol and practically insoluble in cyclohexane. - image 1

tablets debossed - image 2

tablets debossed - image 2

tablets debossed - image 3

tablets debossed - image 3

small image - image 4

small image - image 4

PRINCIPAL DISPLAY PANEL NDC 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only - image 5

PRINCIPAL DISPLAY PANEL NDC 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only - image 5

This is a medication guide for Buprenorphine Il sublingual tablets. The tablets are dispensed in a tight light-resistant container with a dosage of 2 mg of buprenorphine base. The usual dosage should be checked in the product information. The medicine guide should be given to each patient by the pharmacist. It also warns to keep the tablets out of reach of children as they will need emergency medical care if they accidentally take buprenorphine. The tablets must store at a temperature range of 25°C to 30°C. The tablets are manufactured by Teva Pharmaceuticals and are available as 30 tablets with a lot/exp below.*

PRINCIPAL DISPLAY PANEL NDC 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only - image 6

PRINCIPAL DISPLAY PANEL NDC 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only - image 6

Buprenorphine 1l Sublingual tablets with NDC0228-3153-03 is a prescription drug. Dispensing pharmacist should provide the medication guide to each patient. The drug is harmful if accidentally taken by children, so keep it out of reach. Each tablet contains Buprenorphine hydrochloride USP equivalent to 8 mg of buprenorphine base. It comes in a container that is light-resistant as defined in the USP. Store the drug at 25°C (77°F); excursions permitted o 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Teva Pharmaceuticals in Parsippany, Nj 07054, manufactures it. There is more information on the lot/exp date below.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.